Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368329 · ClinicalTrials.gov registry record · Phase 1
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
A Phase 1 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00368329: Clinical Trial Phase 1 study, sponsored by Stanford University.
NCT00368329 is a Phase 1 study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00368329, a Phase 1 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
To study the safety and feasibility of stereotactic radiation dose escalation following neoadjuvant chemotherapy with concurrent conventionally fractionated radiation, by evaluating the acute and late toxicity of treatment.
Interventions
- DRUG Carboplatin
- DRUG 5-Fluorouracil (5-FU)
- DRUG Capecitabine (Xeloda)
- DRUG [18-F] Fluorodeoxyglucose (FDG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Why NCT00368329 stopped before completion
NCT00368329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Carboplatin is the first listed.
NCT00368329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00368329 about?
NCT00368329 is a clinical study titled "Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer". To study the safety and feasibility of stereotactic radiation dose escalation following neoadjuvant chemotherapy with concurrent conventionally fractionated radiation, by evaluating the acute and late toxicity of treatment.
What is the current status of trial NCT00368329?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2006-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00368329?
The interventions under investigation include: Carboplatin (DRUG), 5-Fluorouracil (5-FU) (DRUG), Capecitabine (Xeloda) (DRUG), [18-F] Fluorodeoxyglucose (FDG) (DRUG).
Who is sponsoring clinical trial NCT00368329?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00368329's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia